title: Estimating cholesterol treatment rates among individuals with multiple risk factors and without coronary heart disease.
abstract: This retrospective study examined lipid-lowering therapy treatment rates from 2000 to 2001 using the Ingenix LabRx Database. Patients with multiple risk factors without coronary heart disease were identified based on the presence of >/=2 of the following: men >/=45 years, women >/=55 years, hypertension, high-density lipoprotein cholesterol <40 mg/dl, total cholesterol >/=200 mg/dl, or obesity. Lipid treatment rates were estimated among those needing therapy (defined as low-density lipoprotein cholesterol >/=130 mg/dl or currently receiving lipid-lowering therapy). The overall lipid-lowering therapy treatment rate was 38% and the estimated lipid treatment gap (percent needing treatment who were not receiving it) was 62%.
authors.affiliation: Outcomes Research and Management, Merck & Co., Inc., West Point, Pennsylvania, USA. soma_nag@merck.com
authors.forename: Soma S
authors.initials: SS
authors.lastname: Nag
authors.forename: Thomas A
authors.initials: TA
authors.lastname: Pearson
authors.forename: Larry
authors.initials: L
authors.lastname: Ma
authors.forename: Pamela B
authors.initials: PB
authors.lastname: Landsman
authors.forename: Anthony
authors.initials: A
authors.lastname: Cimino
authors.forename: Florence F
authors.initials: FF
authors.lastname: Vickers
authors.forename: Charles M
authors.initials: CM
authors.lastname: Alexander
authors.forename: Jeffrey M
authors.initials: JM
authors.lastname: Melin
mesh_terms: D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D008078:Cholesterol, LDL / Q000097:blood; D003327:Coronary Disease / Q000150:complications / Q000517:prevention & control*; D005260:Female; D006801:Humans; D006937:Hypercholesterolemia / Q000150:complications / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D012307:Risk Factors
chemical_list: D000924:Anticholesteremic Agents; D008078:Cholesterol, LDL